You are here

  • Home
  • Archive
  • Volume 10, Issue 6
  • Inhaled recombinant human IL-15 in dogs with naturally occurring pulmonary metastases from osteosarcoma or melanoma: a phase 1 study of clinical activity and correlates of response

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Inhaled recombinant human IL-15 in dogs with naturally occurring pulmonary metastases from osteosarcoma or melanoma: a phase 1 study of clinical activity and correlates of response

 

Online download statistics by month:

Online download statistics by month: June 2022 to August 2025

AbstractFullPdf
Jun 202216721709258
Jul 2022881898132
Aug 202244845965
Sep 2022685696156
Oct 202237438178
Nov 202232132669
Dec 202247748071
Jan 202323624653
Feb 202328328852
Mar 202320620654
Apr 202316216636
May 202313914141
Jun 202312012032
Jul 202311011040
Aug 2023747725
Sep 202310110134
Oct 202311111138
Nov 202313713750
Dec 202310310328
Jan 202410410639
Feb 202414314345
Mar 202413013184
Apr 202411711735
May 202410110034
Jun 202411611635
Jul 2024118121445
Aug 2024838223
Sep 202410210237
Oct 202410210240
Nov 202411812030
Dec 202413013421
Jan 202510610671
Feb 202514314349
Mar 202511411566
Apr 202518218257
May 2025999958
Jun 2025868650
Jul 2025220
Aug 2025100
Total873788622531